HC Surgical Specialists Ltd
1B1Healthcare – Outpatient Surgical / Endoscopy ClinicsHC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other general and specialized medical services. In addition, the company provides orthopedic services comprising joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, wounds/lumps, tenosynovitis, tunnel syndrome, bumps, joint replacement, arthroscopic surgery, knee osteotomy, realignment surgery, endoscopic spine surgery, disc replacements, spinal decompression, fractures, and orthobiologic injections. Further, it provides home care services, which include medical, nursing, physiotherapy, speech therapy, occupational therapy, and ambulance services; health screening, management of acute and chronic conditions, and pre-employment check-up; public health preparedness clinic scheme, swab and send home program, community health assist scheme, and COVID-19 swab test services. Additionally, the company offers diagnostic tests that comprise blood tests, X-Rays, ultrasound, CT scans, and MRIs. HC Surgical Specialists Limited was incorporated in 2015 and is based in Singapore.
Each figure shows where it came from. How we source our numbers →
Dividends
No upcoming ex-date announced yet.
2026 dividends: S$0.009 per security · indicative yield 2.57% at S$0.35 last.
Pays Annual · 5 years of dividends on record, from 2022 onwards.
Full dividend history
| Ex-Date | Amount / Security |
|---|---|
| 02 Mar 2026 | S$0.009 |
| 31 Oct 2025 | S$0.0118 |
| 28 Feb 2025 | S$0.008 |
| 08 Nov 2024 | S$0.007 |
| 29 Feb 2024 | S$0.007 |
| 09 Nov 2023 | S$0.01 |
| 01 Mar 2023 | S$0.01 |
| 31 Oct 2022 | S$0.012 |
Dividends by year
| Year | Total / Security | Yield* |
|---|---|---|
| 2026 | S$0.009 | 2.57% |
| 2025 | S$0.0198 | 5.66% |
| 2024 | S$0.014 | 4.00% |
| 2023 | S$0.02 | 5.71% |
| 2022 | S$0.026 | 7.43% |
*Yield uses the current last price (S$0.35) against each year's total — indicative only.
Earnings
No earnings data yet for this counter.
Announcements & news
- SGX page for 1B1 ↗Price, trading data and this counter's own announcements
- SGX company announcements ↗Every counter's filings, if you need to search across them
- Investor relations ↗HC Surgical Specialists Ltd's own results and presentations
- Latest news ↗Press coverage and commentary
PE reported 5.75x-6.38x across sources; small-cap, thinly traded.
Price synced from SGX. Other figures carry their own source and date above. How we source our numbers